Drug Shortage Report for MULTI 12 INJECTION
Report ID | 100121 |
Drug Identification Number | 02100606 |
Brand name | MULTI 12 INJECTION |
Common or Proper name | MULTI-12 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN B1 VITAMIN B2 BIOTIN FOLIC ACID DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN C VITAMIN E VITAMIN D VITAMIN A VITAMIN B12 |
Strength(s) | 0.6MG 0.72MG 12MCG 80MCG 3MG 0.8MG 8MG 20MG 2UNIT 40UNIT 660UNIT 1MCG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 10 Vials |
ATC code | B05XC |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-12-02 |
Estimated end date | 2019-12-18 |
Actual end date | 2019-12-23 |
Shortage status | Resolved |
Updated date | 2019-12-24 |
Company comments | Limited supply at Baxter - On allocation at 100% of historical usage |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-03 | English | Compare |
v2 | 2019-12-03 | French | Compare |
v3 | 2019-12-23 | English | Compare |
v4 | 2019-12-23 | French | Compare |
v5 | 2019-12-24 | English | Compare |
Showing 1 to 5 of 5